Clinical trial
Paclitaxel in Treating Patients With Advanced Head and Neck Cancer
NCT00002922 · Eastern Cooperative Oncology Group, Other · Completed
Key facts
| NCT number | NCT00002922 |
|---|---|
| Title | Paclitaxel in Treating Patients With Advanced Head and Neck Cancer |
| Official title | Phase II Evaluation of Paclitaxel Infusion in Advanced (Recurrent or Metastatic) Squamous Cell Carcinoma of the Head and Neck |
| Lead sponsor | Eastern Cooperative Oncology Group, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Head and Neck Cancer |
| Intervention type | Drug |
| Interventions | paclitaxel |
| Start date | Feb 21, 1997 |
| Primary completion | Sep 1, 2001 |
| First posted | Jul 7, 2004 |
| Last update posted | Jun 18, 2023 |
| Countries | South Africa, United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: